← FDA Drug Approvals (Drugs@FDA)

NALBUPHINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IGI LABS INC

Drug application

FDA Application #

ANDA072075

Application type

Abbreviated New Drug Application (Generic)

Brand name

NALBUPHINE HYDROCHLORIDE

Generic name

Nalbuphine Hydrochloride

Active ingredients

NALBUPHINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

IGI LABS INC

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown